Top-News
Gesundheitswesen: Ausstattung u. Produkte USA

Artivion Inc News

Aktie
WKN:  900006 ISIN:  US2289031005 US-Symbol:  AORT
25,65 €
+0,35 €
+1,38%
25.07.24
Handeln Depot/Watchlist
Aktienanzahl *
41,23 Mio.
Marktkapitalisierung *
1,04 Mrd. €
Streubesitz
9,60%
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 11.03.2024

Artivion Inc News

25.07.24 - PR Newswire
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2024 Financial Results PR Newswire
01.07.24 - PR Newswire
Artivion Amends Agreements with Endospan
Artivion Amends Agreements with Endospan PR Newswire
06.05.24 - PR Newswire
Artivion Reports First Quarter 2024 Financial Results
Artivion Reports First Quarter 2024 Financial Results PR Newswire
29.04.24 - PR Newswire
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting
Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual Meeting PR ...
22.04.24 - PR Newswire
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results
Artivion Announces Release Date and Teleconference Call Details for First Quarter 2024 Financial Results PR Newswire
01.04.24 - PR Newswire
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Artivion to Participate in the 23rd Annual Needham Virtual Healthcare Conference PR Newswire
06.03.24 - PR Newswire
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Artivion to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference PR Newswire
15.02.24 - PR Newswire
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results
Artivion Reports Fourth Quarter and Full Year 2023 Financial Results PR Newswire
01.02.24 - PR Newswire
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2023 Financial Results PR Newswire
29.01.24 - PR Newswire
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting
Artivion Announces Presentation of Late-​Breaking Data from AMDS PERSEVERE Trial at the 60th Society of Thoracic Surgery Annual Meeting PR Newswire
06.12.23 - PR Newswire
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer
Artivion Appoints Lance A. Berry as Executive Vice President, Chief Financial Officer; Announces Retirement of D. Ashley Lee, Chief Financial Officer PR Newswire
21.11.23 - PR Newswire
Thinking about buying stock in Devon Energy, NextEra Energy, Datadog, Heart Test Laboratories, or Artivion?
Thinking about buying stock in Devon Energy, NextEra Energy, Datadog, Heart Test Laboratories, or Artivion? PR Newswire
09.11.23 - PR Newswire
Artivion Announces Completion of Enrollment in PERSEVERE Trial
Artivion Announces Completion of Enrollment in PERSEVERE Trial PR Newswire
08.11.23 - PR Newswire
Artivion to Participate in Upcoming Investor Conferences
Artivion to Participate in Upcoming Investor Conferences PR Newswire
02.11.23 - PR Newswire
Artivion Reports Third Quarter 2023 Financial Results
Artivion Reports Third Quarter 2023 Financial Results PR Newswire
19.10.23 - PR Newswire
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results PR Newswire
05.10.23 - PR Newswire
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin
Artivion Announces Presentation of Real World Data from Post Market Study of On-X® Aortic Heart Valve Replacement Patients Treated with Low Dose Warfarin PR Newswire
05.10.23 - PR Newswire
Artivion Announces Presentation of Late-Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-Thoracic Surgery Annual Meeting
Artivion Announces Presentation of Late-​Breaking Interim Data from AMDS PERSEVERE Trial at the 37th European Association for Cardio-​Thoracic Surgery Annual Meeting PR ...
26.09.23 - PR Newswire
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference
Artivion to Present at the Deutsche Bank 31st Annual Leveraged Finance Conference PR Newswire
14.09.23 - PR Newswire
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase PR Newswire

Newssuche

Videos

newspaper
25.07.24 -7,23%
Technical Trading: DAX Short Chance
DAX Short Typ: Turbo Open End WKN: PG4LWT Hebel: 8,5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »